Capstar Special Purpose Acquisition Corp. Announces the Resignation of Jamie Weinstein as Member of the Board
December 14, 2021 at 06:08 am EST
Share
On December 12, 2021, Jamie Weinstein notified Capstar Special Purpose Acquisition Corp. (the “Company”) that he no longer supported the proposed business combination of the Company with Gelesis Inc., and for that reason was resigning his position as a member of the board of directors, effective immediately. At the time of his resignation, Mr. Weinstein was not a member of any of the Company’s board committees. The Company's board of directors has no immediate plans to appoint a replacement for Mr. Weinstein, although reserves the right to do so.
Gelesis Holdings, Inc. is a commercial stage biotherapeutics company built for consumer engagement. The Company focuses on advancing superabsorbent hydrogel therapeutics for chronic gastrointestinal (GI) diseases including excess weight, type two diabetes, Nonalcoholic Fatty Liver Disease (NAFLD)/ Nonalcoholic Steatohepatitis (NASH), functional constipation (FC), and inflammatory bowel disease. Its product, Plenity, is an orally administered capsule. Plenity is available by prescription via a telehealth consultation with a physician trained in weight management support, with free, unlimited follow-up visits as needed. Consumers can visit myplenity.com for online consultations. Its other pipeline candidate includes GS200 for weight loss in prediabetes and type two diabetes. It is also developing GS300 for the treatment of NAFLD and NASH, and GS500 for the treatment of Functional Constipation (FC).
GELESIS HOLDINGS, INC. 
